Sign in

CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company

Corvus Pharmaceuticals, Inc.

Sign in to watch
Ticker
CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464670809
Phone
(650) 900-4520
Business address
901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. 8-K Event Shareholder vote results
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. DEFA14A Proxy Proxy Materials
  5. DEF 14A Proxy Proxy Statement
  6. 8-K Event Other events
  7. 8-K Event Other events
  8. SC 13D Stake Beneficial Ownership Report
  9. SC 13G Stake Amended Statement of Ownership
  10. SC 13D/A Stake Beneficial Ownership Report
  11. 4 Open-market buy Director bought 588,235 shares at $8.50 ($4,999,998)
  12. 4 Open-market buy Director bought 588,235 shares at $8.50 ($4,999,998)
  13. 4 Open-market buy 10% owner bought 1,176,470 shares at $8.50 ($9,999,995)
  14. 4 Open-market buy Director bought 588,235 shares at $8.50 ($4,999,998)
  15. S-8 Other Securities Offered to Employees in Benefit Plans
  16. 4 Open-market buy 10% owner bought 588,235 shares at $8.50 ($4,999,998)
  17. 4 Open-market buy President and CEO bought 100,000 shares at $8.50 ($850,000)
  18. 424B5 Offering Prospectus
  19. 424B5 Offering Prospectus
  20. 10-K Report Annual Report

Page 22 of 30 · 584 filings